China BlueChemical Affirms Stable Capital Structure and Meets Public-Float Requirement in March 2026 Filing

Bulletin Express04-02

China BlueChemical Ltd. filed its Monthly Return for the period ended 31 March 2026, confirming an essentially unchanged equity profile and continued compliance with Hong Kong’s public-float rules.

Authorised / registered capital • The company’s authorised share capital remained at RMB 4.61 billion, split between 1.80 billion H shares and 2.81 billion domestic shares, each with a par value of RMB 1. • The only technical movement was an increase of one domestic share, leaving totals effectively flat versus February.

Issued shares and treasury shares • Issued H shares: 1.80 billion, unchanged month-on-month. • Issued domestic shares: 2.81 billion, unchanged. • No treasury shares were held or cancelled during the month, maintaining the total issued share count at 4.61 billion.

Public-float confirmation • China BlueChemical confirmed that its H-share public float satisfies the Main Board minimum threshold of 25 percent of the class’s issued shares.

Capital instruments • The company reported no outstanding share options, warrants, convertibles or other equity-linked instruments.

Administrative details • The return was signed by Company Secretary Kuang Xiaobing and submitted to Hong Kong Exchanges and Clearing on 2 April 2026.

The filing signals a steady capital base with no equity dilution events in March, while reaffirming regulatory compliance on public float and share-registration requirements.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap
Leave a comment